CVE-2026-21980
Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences...
Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- Low
- Integrity
- Low
- Availability
- None
Exploit likelihood
What each source reports
CVE List Score used
Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
- Record
CVE-2026-21980- CVSS 3.1
- 6.5 Medium
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N - Updated
- 2026-11-02
EUVDEUVD-2026-3532
Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
- Record
EUVD-2026-3532- CVSS 3.1
- 6.5 Medium
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-xxf9-4c23-v3mw
Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences...
Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
- Record
GHSA-xxf9-4c23-v3mw- CVSS 3.1
- 6.5 Medium
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N - Updated
- 2026-11-02
NVD
Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
- Record
CVE-2026-21980- CVSS 3.1
- 6.5 Medium
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N - Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2026-21980 is a medium vulnerability (CVSS 6.5) in Oracle Life Sciences Central Coding, published January 20, 2026. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.22%, the 12th percentile. No source names a fixed version.